| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |